Table 1 Expression of claudin-6, occludin and MMP-2and clinicopathological characteristics in breast carcinoma patients

Patient Age

 20-40

9

6

3

0.696^*

4

5

0.846^*

6

3

0.900^*

 41-60

20

14

6

11

9

15

5

 61-80

7

5

2

4

3

5

2

Histology

 Ovarian papillary serous carcinoma

36

25

11

0.007

19

17

0.108^*

26

10

0.001

 Ovarian serous adenomas

26

9

17

19

7

8

18

Pathological Grade

 I

14

9

5

0.696^*

8

6

0.918^*

9

5

0.6820^*

 II

12

8

4

6

6

9

3

 III

10

8

2

5

5

8

2

Clinical Stage

 I-II

20

13

7

0.777^*

10

10

0.709^*

11

9

0.028

 III-IV

16

12

4

9

7

15

1

Metastasis

 Positive

13

11

2

0.267^*

7

6

0.923^*

12

1

0.037

 Negative

23

14

9

12

11

14

9